NHS says no to breast cancer drug A pioneering new breast cancer treatment will not be routinely available on the NHS in England, the official drugs advisory body is proposing. BBC News
See also:
See also:
- Pressure grows on Roche to lower breast cancer drug price NICE
- Breast cancer (HER2 positive, unresectable) - trastuzumab emtansine (after trastuzumab & taxane) NICE draft guideline
- VIDEO: Breast cancer drug 'too expensive' BBC News
- NICE rejects another breast cancer drug that can extend life Daily Mail
- Drugs watchdog condemns Roche for high price of breast cancer therapy The Guardian
- Cancer Drugs Fund seems to help pharmaceuticals giant Roche most The Guardian
- Pharmaceuticals giant Roche blasted for refusing to make breast cancer drug Kadcyla affordable The Independent
No comments:
Post a Comment